Sodium Glucose Co-Transporter 2 Inhibitors Use in Diabetic Patients with Cirrhosis Improves Liver-related Outcomes and Survival [0.03%]
钠葡萄糖共转运蛋白2抑制剂用于糖尿病合并肝硬化患者可改善肝脏预后和远期生存率
Sajid Jalil,Khurram Bari,Khalid Mumtaz et al.
Sajid Jalil et al.
Background: The liver outcomes of SGLT-2 inhibitor (SGLT-2i) in T2DM patients with cirrhosis have not been well studied. Methods: We co...
Clarifying development and validation claims for a bowel-preparation prediction tool [0.03%]
澄清肠准备预测工具的开发与验证声明
Anastasios Koulaouzidis,Ervin Toth,Wojciech Marlicz
Anastasios Koulaouzidis
Measuring Perceived Goal Concordant Care Among Patients with Advanced Chronic Liver Diseases and their Caregivers [0.03%]
测量晚期慢性肝病患者及其照护者对共同目标护理的感知情况
Manisha Verma,Victor Navarro,Bryce B Reeve et al.
Manisha Verma et al.
Background: High-quality care in advanced chronic liver disease (CLD) requires alignment between patients' goals and preferences and the care delivered. However, no validated instruments exist to measure perceived goal-co...
Establishment and Evaluation of a Probe-based Confocal Laser Endomicroscopy Training System for Gastric Cancerous Lesions Diagnosis: Evidence from a National Training Program [0.03%]
基于探针的共聚焦激光内镜训练系统在中国胃癌病变诊断中的建立及评估：一项国家级培训项目的证据支持
Peng Pan,Jie Gao,Yu Zhang et al.
Peng Pan et al.
Introduction: The learning process for probe-based confocal laser endomicroscopy (pCLE) is challenging, and standardized training protocols are currently lacking. The main purpose of this study is to establish and evaluat...
Trajectory of Ascites Pressure and Outcomes of Patients with Cirrhosis Undergoing Paracentesis [0.03%]
肝硬化患者进行腹腔穿刺的腹水压力轨迹及结局
Nikhilesh R Mazumder,Max Macgregor,John D Rice et al.
Nikhilesh R Mazumder et al.
Background: Ascites severity is an important prognostic marker of liver disease. We hypothesize that ascites pressure correlates with outcomes of patients undergoing therapeutic paracentesis. ...
Comparative Efficacy and Safety of Octreotide, Lanreotide, and Pasireotide in ADPKD and PLD: A Network Meta-analysis with Real-world Evidence from the FAERS Database [0.03%]
基于FAERS数据库的真实世界证据的奥曲肽、兰瑞肽和帕司丽肽在ADPKD及PLD中的网络meta分析：有效性和安全性的比较
Ziwei Mei,Jun Chen,Junfen Fan et al.
Ziwei Mei et al.
Somatostatin analogs were the primary treatment for autosomal dominant polycystic kidney disease (ADPKD) or polycystic liver disease (PLD), including octreotide, lanreotide, and pasireotide. We compared the effects and safety of octreotide,...
Glucosyl hesperidin benefits in primary biliary cholangitis: a multicenter, open-label, randomized controlled study [0.03%]
葡萄糖 hesperidin 在原发性胆汁性肝硬化中的疗效：一项多中心、开放标签、随机对照研究
Kei Moriya,Kiyoshi Asada,Naoki Ozu et al.
Kei Moriya et al.
Introduction: Primary biliary cholangitis (PBC) has steadily increased in incidence, but its causes remain to be completely elucidated. Moreover, the potential for disease progression is not uncommon, especially when norm...
Cost effectiveness of modalities of Palliative Biliary Drainage in Malignant Extrahepatic Biliary Obstruction [0.03%]
恶性胆管梗阻不同姑息性胆道引流方式的成本效果分析
Abdullah Abbasi,Shyam Menon
Abdullah Abbasi
Introduction: Biliary drainage in malignant extrahepatic distal bile duct obstruction (MBO) can be achieved with Endoscopic Retrograde Cholangiopancreatography (ERCP), Percutaneous Transhepatic Biliary Drainage (PTBD) or ...